GLP-1s and blindness: 6 things to know
Thousands of lawsuits, including at least 4,000 consolidated claims, allege GLP-1 drugs such as Ozempic, Wegovy, Zepbound and Trulicity have caused vision loss, with a recent wave focused specifically on nonarteritic anterior ischemic optic neuropathy, according to a Sept. 21 USA Today report. Here are six things to know: The post GLP-1s and blindness: 6 things to know appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.